BIOLEXIS THERAPEUTICS INC.

Profile

Company Names

BIOLEXIS THERAPEUTICS INC.
BIOLEXIS THERAPEUTICS, INC.

Addresses

3900 N TRAVERSE MOUNTAIN BLVD, SUITE 200, LEHI, UT 84043

858 S AUTO MALL DRIVE, SUITE 102, AMERICAN FORK, UT 84003

9980 SOUTH, 300 WEST, SUITE #200, SANDY, UT 84070

Phone Numbers

801-328-3600
801-550-8088

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$6,325,000.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2026-05-20 
$1,600,000.00 
$12,000,000.00 
$10,400,000.00 
 
4
2023-10-03 
$1,000,000.00 
INDEFINITE 
INDEFINITE 
Equity 
3
2023-09-19 
$725,000.00 
$725,000.00 
$0.00 
Equity 
2
2022-08-18 
$1,500,000.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2022-02-03 
$1,500,000.00 
$2,000,000.00 
$500,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
J. 
BEARSS 
DIRECTOR, EXECUTIVE OFFICER
DR. DAVID 
J. 
BEARSS 
EXECUTIVE OFFICER, DIRECTOR
JAMES 
N. 
CLARKE 
DIRECTOR
TYLER 
 
HARTMANN 
EXECUTIVE OFFICER
ANTHONY 
 
STEVE 
DIRECTOR
DAVID 
O. 
TAYLOR 
EXECUTIVE OFFICER, DIRECTOR
DR. HARIPRASAD 
 
VANKAYALAPATI 
EXECUTIVE OFFICER, DIRECTOR
HARIPRASAD 
 
VANKAYALAPATI 
DIRECTOR, EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2026-05-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-09-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-02-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#